241 related articles for article (PubMed ID: 36367007)
1. Blosozumab in the treatment of postmenopausal women with osteoporosis: a systematic review and meta-analysis.
Su Y; Wang W; Liu F; Cai Y; Li N; Li H; Li G; Ma L
Ann Palliat Med; 2022 Oct; 11(10):3203-3212. PubMed ID: 36367007
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.
Recknor CP; Recker RR; Benson CT; Robins DA; Chiang AY; Alam J; Hu L; Matsumoto T; Sowa H; Sloan JH; Konrad RJ; Mitlak BH; Sipos AA
J Bone Miner Res; 2015 Sep; 30(9):1717-25. PubMed ID: 25707611
[TBL] [Abstract][Full Text] [Related]
3. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.
Recker RR; Benson CT; Matsumoto T; Bolognese MA; Robins DA; Alam J; Chiang AY; Hu L; Krege JH; Sowa H; Mitlak BH; Myers SL
J Bone Miner Res; 2015 Feb; 30(2):216-24. PubMed ID: 25196993
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
[TBL] [Abstract][Full Text] [Related]
6. Single- and multiple-dose randomized studies of blosozumab, a monoclonal antibody against sclerostin, in healthy postmenopausal women.
McColm J; Hu L; Womack T; Tang CC; Chiang AY
J Bone Miner Res; 2014 Apr; 29(4):935-43. PubMed ID: 23996473
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Su S; He N; Men P; Song C; Zhai S
Osteoporos Int; 2019 Jun; 30(6):1175-1186. PubMed ID: 30734066
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials (CDM-J).
Huang W; Nagao M; Yonemoto N; Guo S; Tanigawa T; Nishizaki Y
Pharmacoepidemiol Drug Saf; 2023 Jun; 32(6):671-684. PubMed ID: 36703260
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
Ma ML; Ma ZJ; He YL; Sun H; Yang B; Ruan BJ; Zhan WD; Li SX; Dong H; Wang YX
Front Public Health; 2022; 10():979649. PubMed ID: 36033779
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
Chen L; Wang G; Zheng F; Zhao H; Li H
Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of walking for preservation of bone mineral density in postmenopausal women.
Martyn-St James M; Carroll S
Bone; 2008 Sep; 43(3):521-31. PubMed ID: 18602880
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of anti-sclerostin antibodies in the treatment of osteoporosis: A meta-analysis and systematic review.
Poutoglidou F; Samoladas E; Raikos N; Kouvelas D
J Clin Densitom; 2022; 25(3):401-415. PubMed ID: 34920938
[TBL] [Abstract][Full Text] [Related]
15. The Safety and Efficacy of Abaloparatide on Postmenopausal Osteoporosis: A Systematic Review and Meta-analysis.
Xu F; Wang Y; Zhu X
Clin Ther; 2024 Mar; 46(3):267-274. PubMed ID: 38307725
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis: A Meta-Analysis.
Gu HF; Gu LJ; Wu Y; Zhao XH; Zhang Q; Xu ZR; Yang YM
Medicine (Baltimore); 2015 Nov; 94(44):e1674. PubMed ID: 26554766
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
Zhou M; Han S; Zhang W; Wu D
J Bone Miner Metab; 2022 Sep; 40(5):763-772. PubMed ID: 35711002
[TBL] [Abstract][Full Text] [Related]
18. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
[TBL] [Abstract][Full Text] [Related]
19. Probiotic supplements and bone health in postmenopausal women: a meta-analysis of randomised controlled trials.
Yu J; Cao G; Yuan S; Luo C; Yu J; Cai M
BMJ Open; 2021 Mar; 11(3):e041393. PubMed ID: 33653743
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: A systematic review and meta-analysis.
Peng L; Luo Q; Lu H
Medicine (Baltimore); 2017 Dec; 96(49):e8659. PubMed ID: 29245225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
